M.A. Med Alliance SA announced that it has entered into an equity agreement of common shares for gross proceeds of $20,000,000 on May 21, 2018. The transaction will include participation from the new investor Shenzhen Salubris Pharmaceuticals Co., Ltd. (SZSE:002294).